The rationale behind the recommendation is that the vaccine
prevents genital warts and anal cancers in males, both of which can be caused by HPV
The panel's recommendation is intended to
prevent genital warts and anal cancers in males, and possibly prevent head and neck cancer (though the vaccine's effectiveness against head and neck cancers has not yet been proven).
Boys and men ages 9 to 26 can get the vaccine to
prevent genital warts, some cancers of the anus, and to prevent the spread of HPV to women, which could potentially cause cancer.
Not exact matches
«Based on epidemiological studies, the 9vHPV vaccine could
prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and
genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.
Two existing HPV vaccines, Cervarix ® and Gardasil ®, are effective at
preventing disease caused by HPV types 16 and 18, while Gardasil also protects against
genital warts caused by HPV 6 and 11.
While it is true that if used properly and consistently condoms are helpful in
preventing certain diseases, such as chlamydia and gonorrhea, they may not fully protect against other diseases such as
genital warts, herpes and syphilis.
There are vaccines that can
prevent high - risk HPV types and the types that cause
genital warts.